APPLIED GENETIC TECHNOLOGIES CORP Annual Income Tax Expense (Benefit) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Applied Genetic Technologies Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to 2022.
  • Applied Genetic Technologies Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
  • Applied Genetic Technologies Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was $0.000.
  • Applied Genetic Technologies Corp annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Applied Genetic Technologies Corp annual Income Tax Expense (Benefit) for 2021 was -$2.11M, a 2640% decline from 2020.
  • Applied Genetic Technologies Corp annual Income Tax Expense (Benefit) for 2020 was $83K, a 9.21% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 +$2.11M Jul 1, 2021 Jun 30, 2022 10-K 2022-09-27
2021 -$2.11M -$2.19M -2640% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
2020 $83K +$7K +9.21% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-23
2019 $76K +$4K +5.56% Jul 1, 2018 Jun 30, 2019 10-K 2020-09-18
2018 $72K -$2.33M -97% Jul 1, 2017 Jun 30, 2018 10-K 2019-09-26
2017 $2.4M Jul 1, 2016 Jun 30, 2017 10-K 2018-09-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.